Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130


Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer.

Beatty PL, Narayanan S, Gariépy J, Ranganathan S, Finn OJ.

Cancer Prev Res (Phila). 2010 Apr;3(4):438-46. doi: 10.1158/1940-6207.CAPR-09-0194. Epub 2010 Mar 23.


Experimental vaccine against inflammatory bowel disease and colon cancer.

[No authors listed]

Immunotherapy. 2010 May;2(3):299. No abstract available.


Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis.

Kadayakkara DK, Beatty PL, Turner MS, Janjic JM, Ahrens ET, Finn OJ.

Pancreas. 2010 May;39(4):510-5. doi: 10.1097/MPA.0b013e3181bd6501.


Downregulation of hematopoietic MUC1 during experimental colitis increases tumor-promoting myeloid-derived suppressor cells.

Poh TW, Madsen CS, Gorman JE, Marler RJ, Leighton JA, Cohen PA, Gendler SJ.

Clin Cancer Res. 2013 Sep 15;19(18):5039-52. doi: 10.1158/1078-0432.CCR-13-0278. Epub 2013 Jul 19.


Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine.

Lakshminarayanan V, Thompson P, Wolfert MA, Buskas T, Bradley JM, Pathangey LB, Madsen CS, Cohen PA, Gendler SJ, Boons GJ.

Proc Natl Acad Sci U S A. 2012 Jan 3;109(1):261-6. doi: 10.1073/pnas.1115166109. Epub 2011 Dec 14.


The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice.

Nishida A, Lau CW, Zhang M, Andoh A, Shi HN, Mizoguchi E, Mizoguchi A.

Gastroenterology. 2012 Apr;142(4):865-874.e2. doi: 10.1053/j.gastro.2011.12.036. Epub 2011 Dec 24.


Tecemotide: an antigen-specific cancer immunotherapy.

Wurz GT, Kao CJ, Wolf M, DeGregorio MW.

Hum Vaccin Immunother. 2014;10(11):3383-93. doi: 10.4161/hv.29836. Review.


Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer.

Mukherjee P, Madsen CS, Ginardi AR, Tinder TL, Jacobs F, Parker J, Agrawal B, Longenecker BM, Gendler SJ.

J Immunother. 2003 Jan-Feb;26(1):47-62.


Induction of immune response and anti-tumor activities in mice with a DNA vaccine encoding human mucin 1 variable-number tandem repeats.

Zhang S, Zhang H, Shi H, Yu X, Kong W, Li W.

Hum Immunol. 2008 Apr-May;69(4-5):250-8. doi: 10.1016/j.humimm.2008.02.006. Epub 2008 Apr 4.


Tumor antigen epitopes interpreted by the immune system as self or abnormal-self differentially affect cancer vaccine responses.

Ryan SO, Turner MS, Gariépy J, Finn OJ.

Cancer Res. 2010 Jul 15;70(14):5788-96. doi: 10.1158/0008-5472.CAN-09-4519. Epub 2010 Jun 29.


Preventing cancer by targeting abnormally expressed self-antigens: MUC1 vaccines for prevention of epithelial adenocarcinomas.

Beatty PL, Finn OJ.

Ann N Y Acad Sci. 2013 May;1284:52-6. doi: 10.1111/nyas.12108.


Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccines.

Sivinski CL, Kohlgraf KG, VanLith ML, Morikane K, Tempero RM, Hollingsworth MA.

Cancer Immunol Immunother. 2002 Aug;51(6):327-40. Epub 2002 May 4.


Aberrant expression of MUC1 mucin in pediatric inflammatory bowel disease.

Furr AE, Ranganathan S, Finn OJ.

Pediatr Dev Pathol. 2010 Jan-Feb;13(1):24-31. doi: 10.2350/08-06-0479.1.


MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model.

Mukherjee P, Pathangey LB, Bradley JB, Tinder TL, Basu GD, Akporiaye ET, Gendler SJ.

Vaccine. 2007 Feb 19;25(9):1607-18. Epub 2006 Nov 16.


Antitumor effects of L-BLP25 antigen-specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model.

Wurz GT, Gutierrez AM, Greenberg BE, Vang DP, Griffey SM, Kao CJ, Wolf M, DeGregorio MW.

J Transl Med. 2013 Mar 13;11:64. doi: 10.1186/1479-5876-11-64.


Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.

Deguchi T, Tanemura M, Miyoshi E, Nagano H, Machida T, Ohmura Y, Kobayashi S, Marubashi S, Eguchi H, Takeda Y, Ito T, Mori M, Doki Y, Sawa Y.

Cancer Res. 2010 Jul 1;70(13):5259-69. doi: 10.1158/0008-5472.CAN-09-4313. Epub 2010 Jun 8.


Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation.

Powell N, Lo JW, Biancheri P, Vossenkämper A, Pantazi E, Walker AW, Stolarczyk E, Ammoscato F, Goldberg R, Scott P, Canavan JB, Perucha E, Garrido-Mesa N, Irving PM, Sanderson JD, Hayee B, Howard JK, Parkhill J, MacDonald TT, Lord GM.

Gastroenterology. 2015 Aug;149(2):456-67.e15. doi: 10.1053/j.gastro.2015.04.017. Epub 2015 Apr 25.

Supplemental Content

Support Center